Correlation Between Gilead Sciences and AbbVie
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and AbbVie Inc, you can compare the effects of market volatilities on Gilead Sciences and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and AbbVie.
Diversification Opportunities for Gilead Sciences and AbbVie
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Gilead and AbbVie is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and AbbVie go up and down completely randomly.
Pair Corralation between Gilead Sciences and AbbVie
Given the investment horizon of 90 days Gilead Sciences is expected to generate 1.27 times more return on investment than AbbVie. However, Gilead Sciences is 1.27 times more volatile than AbbVie Inc. It trades about 0.27 of its potential returns per unit of risk. AbbVie Inc is currently generating about 0.33 per unit of risk. If you would invest 9,296 in Gilead Sciences on November 19, 2024 and sell it today you would earn a total of 1,112 from holding Gilead Sciences or generate 11.96% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Gilead Sciences vs. AbbVie Inc
Performance |
Timeline |
Gilead Sciences |
AbbVie Inc |
Gilead Sciences and AbbVie Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gilead Sciences and AbbVie
The main advantage of trading using opposite Gilead Sciences and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |